Cardiac tamponade as an inherent but potentially nonfatal complication of transvenous lead extraction: Experience with 1126 procedures performed using mechanical tools.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
12 2022
Historique:
revised: 20 07 2022
received: 20 03 2022
accepted: 29 08 2022
pubmed: 3 9 2022
medline: 16 12 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

Cardiac tamponade (CT) is one of the most common and dangerous complications of transvenous lead extraction (TLE). So far, however, there has been little discussion about the problem. We analyzed the occurrence of CT in a group of 1226 patients undergoing TLE at a single reference center between June, 2015 and February, 2021. Using standard mechanical devices as first-line tools, a total of 2092 leads had been extracted. CT occurred in 18 patients (1.47%): due to injury to the wall of the right atrium in 14 patients (1.14%) and other cardiac walls in four patients (0.33%). Younger patient age at first implantation, female gender, high left ventricular ejection fraction (LVEF), lower New York Heart Association class, low Charlson comorbidity index, longer implant duration, and the number of previous procedures related to cardiac implantable electronic devices (CIED) are important patient-related risk factors for CT. Significant procedure-related risk factors include the number of extracted leads, extraction of atrial leads and longer dwell time of extracted leads. Intraoperative transoesophageal echocardiography (TEE) provides a lot of information about pulling on various cardiac structures and is able to detect a very early phase of bleeding to the pericardial sac. As a result of implementing best practices guidance in performing extraction procedures and close collaboration with cardiac surgeons that allowed immediate rescue intervention in our series of 18 CT cases, there were no procedure-related deaths (mortality 0%). The need for rescue surgery due to CT has no influence on clinical and procedural success. Early diagnosed (TEE monitoring) and properly managed CT does not generate any additional risk in short- and long-term follow-up after TLE.

Identifiants

pubmed: 36054327
doi: 10.1111/jce.15668
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2625-2639

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Love CJ, Wilkoff BL, Byrd CL, et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. Pacing Clin Electrophysiol. 2000;23:544-551.
Wilkoff BL, Love CJ, Byrd CL, et al. Heart rhythm society; American Heart Association. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6:1085-1104.
Deharo JC, Bongiorni MG, Rozkovec A, et al. European Heart Rhythm Association. Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper. Europace. 2012;14:124-134.
Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;2017(14):e503-e551.
Bongiorni MG, Burri H, Deharo JC, et al. EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace. 2018;2018:1-11.
Brunner MP, Cronin EM, Wazni O, et al. Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction. Heart Rhythm. 2014;11:419-425.
Wang W, Wang X, Modry D, Wang S. Cardiopulmonary bypass standby avoids fatality due to vascular laceration in laser-assisted lead extraction. J Card Surg. 2014;29:274-278.
Bashir J, Fedoruk LM, Ofiesh J, Karim SS, Tyers GFO. Classification and surgical repair of injuries sustained during transvenous lead extraction. Circ Arrhythm Electrophysiol. 2016;9:e003741.
Maus TM, Shurter J, Nguyen L, Birgersdotter-Green U, Pretorius V. Multidisciplinary approach to transvenous lead extraction: a single center's experience. J Cardiothorac Vasc Anesth. 2015;29:265-270.
Caniglia-Miller JM, Bussey WD, Kamtz NM, et al. Surgical management of major intrathoracic hemorrhage resulting from high-risk transvenous pacemaker/defibrillator lead extraction. J Card Surg. 2015;30:149-153.
Azarrafiy R, Tsang DC, Wilkoff BL, Carrillo RG. Endovascular occlusion balloon for treatment of superior vena cava tears during transvenous lead extraction: a multiyear analysis and an update to best practice protocol. Circ Arrhythm Electrophysiol. 2019;12:e007266.
Hosseini SM, Rozen G, Kaadan MI, Galvin J, Ruskin JN. Safety and in-hospital outcomes of transvenous lead extraction for cardiac implantable device-related infections: analysis of 13 years of inpatient data in the United States. JACC Clin Electrophysiol. 2019;5:1450-1458.
Hauser RG, Katsiyiannis WT, Gornick CC, Almquist AK, Kallinen LM. Deaths and cardiovascular injuries due to device assisted implantable cardioverter-defibrillator and pacemaker lead extraction. Europace. 2010;12:395-401.
Kutarski A, Czajkowski M, Pietura R, et al. Effectiveness, safety, and long-term outcomes of non-powered mechanical sheaths for transvenous lead extraction. Europace. 2018;20:1324-1333.
Issa ZF. Transvenous lead extraction in 1000 patients guided by intraprocedural risk stratification without surgical backup. Heart Rhythm. 2021;18:1272-1278.
Roberto M, Sicuso R, Manganiello S, et al. Cardiac surgeon and electrophysiologist shoulder-to-shoulder approach: hybrid room, a kingdom for two. A zero mortality transvenous lead extraction single center experience. Int J Cardiol. 2019;279:35-39.
Gaca JG, Lima B, Milano CA, et al. Laser-assisted extraction of pacemaker and defibrillator leads: the role of the cardiac surgeon. Ann Thorac Surg. 2009;87:1446-1450.
Starck CT, Rodriguez H, Hürlimann D, et al. Transvenous lead extractions: comparison of laser vs. mechanical approach. Europace. 2013;15:1636-1641.
Lee SY, Allen IE, Diaz C, et al. Efficacy and mortality of rotating sheaths versus laser sheaths for transvenous lead extraction: a meta-analysis. J Interv Card Electrophysiol. Published online November 27, 2021. doi:10.1007/s10840-021-01076-x
Diaz CL, Guo X, Whitman IR, et al. Reported mortality with rotating sheaths vs. laser sheaths for transvenous lead extraction. Europace. 2019;21:1703-1709.
Gaubert M, Giorgi R, Franceschi F, et al. Outcomes and costs associated with two different lead-extraction approaches: a single-centre study. Europace. 2017;19:1710-1716.
Bongiorni MG, Kennergren C, Butter C, et al. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes. Eur Heart J. 2017;38:2995-3005.
Zucchelli G, Di Cori A, Segreti L, et al. Major cardiac and vascular complications after transvenous lead extraction: acute outcome and predictive factors from the ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) registry. Europace. 2019;21(5):771-780.
Stefańczyk P, Nowosielecka D, Tułecki Ł, Tomków K, Polewczyk A, Jacheć W, et al. Transvenous lead extraction without procedure-related deaths in 1000 consecutive patients: a single-center experience. Vasc Health Risk Manag. 2021;17:445-459.
Nowosielecka D, Jacheć W, Polewczyk A, et al. Transesophageal echocardiography as a monitoring tool during transvenous lead extraction-does it improve procedure effectiveness? J Clin Med. 2020;9:1382.
Nowosielecka D, Polewczyk A, Jacheć W, et al. A new approach to the continuous monitoring of transvenous lead extraction using transesophageal echocardiography-analysis of 936 procedures. Echocardiography. 2020;37:601-611.
Nowosielecka D, Polewczyk A, Jacheć W, et al. Transesophageal echocardiography for the monitoring of transvenous lead extraction. Kardiol Pol. 2020;78:1206-1214.
Jacheć W, Polewczyk A, Polewczyk M, Tomasik A, Kutarski A. Transvenous lead extraction SAFeTY score for risk stratification and proper patient selection for removal procedures using mechanical tools. J Clin Med. 2020;9:361-356.
Nowosielecka D, Jacheć W, Polewczyk A, Kleinrok A. The prognostic value of transesophageal echocardiography after transvenous lead extraction: landscape after battle. Cardiovasc Diagn Ther. 2021;11:394-410.
Tułecki Ł, Czajkowski M, Targońska S, et al. The role of cardiac surgeon in transvenous lead extraction: experience from 3462 procedures. Cardiovasc Electrophysiol. 2022;33:1357-1365. doi:10.1111/jce.15510
Di Cori A, Auricchio A, Regoli F, et al. Clinical impact of antithrombotic therapy in transvenous lead extraction complications: a sub-analysis from the ESC-EORP EHRA ELECTRa (European Lead Extraction ConTRolled) Registry. Europace. 2019;21:1096-1105.

Auteurs

Dorota Nowosielecka (D)

Department of Cardiology, The Pope John Paul II Province Hospital, Zamość, Poland.
Department of Cardiac Surgery, The Pope John Paul II Province Hospital, Zamość, Poland.

Łukasz Tułecki (Ł)

Department of Cardiac Surgery, The Pope John Paul II Province Hospital, Zamość, Poland.

Wojciech Jacheć (W)

Department of Cardiology, Zabrze, Faculty of Medical Science in Zabrze, Medical University of Silesia in Katowice, Poland, Poland.

Anna Polewczyk (A)

Department of Physiology, Pathophysiology and Clinical Immunology, Collegium Medicum of Jan Kochanowski University, Kielce, Poland.
Department of Cardiac Surgery, Świętokrzyskie Cardiology Center, Kielce, Poland.

Konrad Tomków (K)

Department of Cardiac Surgery, The Pope John Paul II Province Hospital, Zamość, Poland.

Paweł Stefańczyk (P)

Department of Cardiology, The Pope John Paul II Province Hospital, Zamość, Poland.

Jarosław Bródka (J)

Department of Cardiac Surgery, The Pope John Paul II Province Hospital, Zamość, Poland.

Andrzej Kutarski (A)

Department of Cardiology, Medical University, Lublin, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH